SCHEMBL20335253

SCHEMBL20335253

O=[S+]c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK11 Q15759 17/20 0.81
MAPK14 Q16539 17/20 0.81
MAPK13 O15264 16/20 0.81
MAPK12 P53778 16/20 0.81
GCGR P47871 14/20 0.81
CSNK1A1 P48729 5/20 0.81
CSNK1D P48730 5/20 0.81
PRKD3 O94806 4/20 0.81
MAP4K4 O95819 4/20 0.81
FRK P42685 4/20 0.81
MAPK9 P45984 4/20 0.81
GSK3B P49841 4/20 0.81
PTK6 Q13882 3/20 0.81
CLK4 Q9HAZ1 3/20 0.81
PRKD2 Q9BZL6 3/20 0.81
ALOX5 P09917 13/20 0.73
ALDH1A1 P00352 4/20 0.71
RIPK2 O43353 3/20 0.71
CYP3A4 P08684 3/20 0.71
ALOX15 P16050 3/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15075603 0.90 MAPK11 (1.00) MAPK11MAPK14MAPK13MAPK12GCGR
SCHEMBL19868925 0.90 MAPK11 (1.00) MAPK11MAPK14MAPK13MAPK12GCGR
SCHEMBL21519839 0.85 MAPK11 (0.73) MAPK11MAPK14MAPK13MAPK12GCGR
SCHEMBL2650702 0.85 MAPK11 (1.00) MAPK11MAPK14MAPK13MAPK12GCGR
SCHEMBL4552316 0.85 MAPK14 (1.00) MAPK11MAPK14MAPK13MAPK12GCGR
SCHEMBL9195042 0.85 MAPK14 (1.00) MAPK11MAPK14MAPK13MAPK12GCGR
SCHEMBL2649616 0.83 MAPK13 (1.00) MAPK11MAPK14MAPK13MAPK12GCGR
SCHEMBL2648930 0.83 MAPK13 (1.00) MAPK11MAPK14MAPK13MAPK12GCGR
Sb-202190 SCHEMBL3386753 0.83 MAPK13 (1.00) MAPK11MAPK14MAPK13MAPK12GCGR
SCHEMBL2648969 0.83 MAPK13 (1.00) MAPK11MAPK14MAPK13MAPK12GCGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3342858-B1 ROR1-POSITIVE MESENCHYMAL STEM CELLS AND METHOD FOR PREPARING SAME, PHARMACEUTICAL COMPOSITION CONTAINING ROR1-POSITIVE MESENCHYMAL STEM CELLS AND METHOD FOR PREPARING SAME, AND METHOD FOR PREVENTING OR TREATING DISEASES BY USING ROR1-POSITIVE MESENCHYMAL STEM CELLS ROHTO PHARMA (JP) 2023-10-04 EP disclosed
US-11707488-B2 ROR1-positive mesenchymal stem cells and method for preparing same, pharmaceutical composition containing ROR1-positive mesenchymal stem cells and method for preparing same, and method for preventing or treating disease using ROR1-positive mesenchymal stem cells ROHTO PHARMACEUTICAL CO., LTD. (JP) 2023-07-25 US disclosed
CN-108350427-B ROR1 positive mesenchymal stem cells and pharmaceutical composition comprising same 日本乐敦制药株式会社 2022-03-11 CN disclosed
US-20200069740-A1 ROR1-POSITIVE MESENCHYMAL STEM CELL-CONTAINING PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DISEASE ASSOCIATED WITH FIBROSIS, METHOD FOR PREPARING SAME, AND METHOD FOR PREVENTING OR TREATING DISEASE ASSOCIATED WITH FIBROSIS USING ROR1-POSITIVE MESENCHYMAL STEM CELLS ROHTO PHARMACEUTICAL CO., LTD. (JP) 2020-03-05 US disclosed
US-20180333436-A1 ROR1-POSITIVE MESENCHYMAL STEM CELLS AND METHOD FOR PREPARING SAME, PHARMACEUTICAL COMPOSITION CONTAINING ROR1-POSITIVE MESENCHYMAL STEM CELLS AND METHOD FOR PREPARING SAME, AND METHOD FOR PREVENTING OR TREATING DISEASE USING ROR1-POSITIVE MESENCHYMAL STEM CELLS ROHTO PHARMACEUTICAL CO., LTD. (JP) 2018-11-22 US disclosed
EP-3342858-A1 ROR1-POSITIVE MESENCHYMAL STEM CELLS AND METHOD FOR PREPARING SAME, PHARMACEUTICAL COMPOSITION CONTAINING ROR1-POSITIVE MESENCHYMAL STEM CELLS AND METHOD FOR PREPARING SAME, AND METHOD FOR PREVENTING OR TREATING DISEASES BY USING ROR1-POSITIVE MESENCHYMAL STEM CELLS Rohto Pharmaceutical Co., Ltd. (JP) 2018-07-04 EP disclosed